Barrett R B Nuttall

5PUBLICATIONS
86CO-AUTHORS
Molecular targetsPredictive and prognostic markersMolecular evolutionCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 15, 2026
Targeting the chromatin modifying enzyme, KDM5C, enhances AKT inhibition response in ER+ breast cancer.

Valentina Cutano, Shanade Dunn, Sungmi Park-Chouinard

|Dec 18, 2025
Characterization of the Immunogenomic Landscape of Ovarian Cancer Uncovers a Distinct Subset of Endometroid Tumors Associated with High CST2 Expression and a Favorable Prognosis.

James Boyle, Jan Zaucha, Felicia Ng

|Oct 11, 2023
Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell Carcinoma.

Maria Secrier, Lara McGrath, Felicia Ng

|Sep 06, 2023
A Type II-B Cas9 nuclease with minimized off-targets and reduced chromosomal translocations in vivo.

Burcu Bestas, Sandra Wimberger, Dmitrii Degtev

|Jun 26, 2023
Phase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment.

Mark Roschewski, Manish R Patel, Patrick M Reagan

Pageof 1

Frequent Collaborators

2 joint publications

Emma V Jones

2 joint publications

Ben S Sidders

2 joint publications

Amelia Raymond

2 joint publications

Helen K Angell